A Targeted Approach
Welcome to Ike Research Solutions, where our team brings over 35 years of combined experience in clinical trial operations across site, CRO, and sponsor arenas.
Our diverse background equips us with a unique perspective, allowing us to understand and address trial challenges from all stakeholders’ vantage points. This enables us to construct comprehensive strategies while also delivering tailored solutions at the individual workstream level.
At Ike Research Solutions, we are committed to guiding your trials to success with expertise and a targeted approach.
In The News
Loading...
-
Revised Declaration of Helsinki Adopted by the Global Medical Community
"The World Medical Association (WMA) has announced the adoption the 2024 Revision of the Declaration of Helsinki (DoH), the global reference for medical research involving human participants, at its General Assembly in Helsinki, Finland." - wma.net
-
Clinical trial site readiness for decentralized trials – fitting trials into today’s world
"Post-pandemic, decentralized clinical trials (DCTs) have emerged as a viable new way to efficiently conduct research. Originally piloted over 15 years ago, adoption of decentralized research methods during the COVID-19 pandemic was necessary to keep critical clinical trials running..." - www.ncbi.nlm.nih.gov
-
Experimental mRNA Vaccine Hints at Potential Against Glioblastoma
"Although immunotherapy is now a mainstay treatment for many cancers, it has yet to break through as a treatment for brain cancer, including the most common type, glioblastoma..." - www.cancer.gov
-
FDA Announces Additional Steps to Modernize Clinical Trials
"Today, the U.S. Food and Drug Administration is announcing the availability of a draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernizing the design and conduct of clinical trials..." - www.fda.gov
-
Clinical Trials and Human Subject Protection
"Protecting the rights, safety and welfare of people who participate in clinical trials is a critical aspect of the FDA’s mission..." - www.fda.gov